Health

Genetic variant in Papua New Guinea’s Fore population found to offer protection against prion diseases

Kuru, a form of transmissible spongiform encephalopathy (TSE), is caused by the misfolding of normal prion proteins into infectious, toxic shapes. Unlike typical genetic disorders, kuru is an acquired condition, transmitted through the consumption of infected human brain and nervous system tissue. The disease shares a pathological lineage with Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE), commonly known as “mad cow disease.” These conditions are invariably fatal, characterized by rapid progression leading to loss of motor control, speech, and eventually death.

The historical context of the kuru epidemic is critical to understanding the genetic findings. In the Eastern Highlands of PNG, the Fore people practiced mortuary feasting, a ritual involving the consumption of deceased relatives. During the peak of the epidemic in the 1950s, up to 2 percent of the Fore population died annually from the disease. The transmission dynamics were heavily influenced by cultural practices; because specific tissues, particularly the brain and spinal cord where prions are concentrated, were apportioned to women and children, these groups suffered disproportionately. This resulted in entire villages being left without adult women, a demographic catastrophe that drew global scientific attention after researchers ruled out environmental contaminants and initial genetic hypotheses.

The recent study, led by the UK Medical Research Council’s prion unit at University College London, represents the most comprehensive genetic analysis of the Eastern Highlands population to date. The researchers discovered that a large number of the Fore population carries a specific genetic variant in the prion protein gene. The hypothesis is that this variant confers resistance to the disease. Consequently, individuals lacking this protective mutation may have been more susceptible to death during earlier kuru outbreaks, leading to a higher prevalence of the variant in the surviving population.

Photo by Tara Winstead on Pexels

To test the protective capacity of this variant, researchers replicated the mutation in mice and infected them with either kuru or Creutzfeldt-Jakob disease strains. The results indicated that mice carrying the same gene variant found in the Fore population were largely protected from the disease and its fatal symptoms. This finding suggests a direct biological mechanism by which the genetic variation prevents the misfolding of prion proteins or neutralizes their infectious potential.

However, medical experts urge caution regarding the generalizability of these findings. Dr. Jiri Safar, co-director of the National Prion Disease Pathology Surveillance Center at Case Western Reserve University, described the finding as a “breakthrough” but emphasized that the variant was tested in only two types of prion disease strains. “It’s very possible that this protective polymorphism may not be protective across all prion strains,” Dr. Safar noted, highlighting a significant caveat for future research. The distinction between laboratory evidence in animal models and clinical applicability in humans remains a crucial gap. While the mouse model provides strong preliminary evidence, it does not definitively prove that the variant offers the same level of protection against all variants of human prion diseases, such as variant CJD.

The study also investigated the broader demographic impacts of the epidemic. Previous assumptions suggested that kuru led to a decrease or cessation of intermarriages between the Fore and neighboring communities, as the disease was sometimes linked to sorcery in local belief systems. However, the new genetic analysis found no evidence for reduced overall migration into areas where kuru was most severe, challenging earlier sociological interpretations of the outbreak’s social footprint.

Photo by Toza Productions on Unsplash

The implications of this research extend beyond understanding a historical epidemic. Prion diseases remain incurable and fatal, and the discovery of a natural protective mutation offers a tangible target for gene therapy or pharmacological development. If scientists can identify the specific molecular mechanism by which this variant confers resistance, it may be possible to develop treatments that mimic this protective effect for the general population at risk from iatrogenic or sporadic prion diseases.

Nevertheless, the transition from observation to treatment is fraught with uncertainty. The protective mechanism was observed in a specific population with a unique exposure history. Whether this variant offers protection against the diverse strains of prion diseases circulating today, or if it carries any unknown fitness costs, remains unanswered. The study underscores the importance of human genetic diversity in uncovering biological defenses against rare but devastating diseases, while reminding the medical community that animal models, while valuable, do not fully replicate the complexity of human neurodegeneration.

As the kuru epidemic has long since dwindled following the outlawing of mortuary feasts in the 1950s, the Fore population serves as a living archive of prion disease epidemiology. Future research will need to determine if this genetic shield is specific to the strains encountered in PNG or if it offers broader protection. Until then, the finding stands as a compelling example of how historical public health crises can yield modern biological insights, though the path from genetic association to clinical cure remains long and unproven.

Amy Cooper

Amy Cooper covers health news, including public-health developments, medical research, healthcare policy, and major findings from scientific studies. She approaches health reporting carefully, giving priority to reputable evidence and clearly identifying what research does and does not establish. Amy's work focuses on accurate, understandable coverage rather than sensational claims, especially when stories involve emerging medical findings.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button